Medication info
Double Low Tablet 40/10 mg

Double Low Tablet 40/10 mg

Prescription medicationTablet경구
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
일양약품(주)
Appearance
White or off-white oblong tablets
Packaging
30 tablets (10 tablets/Alu-Alu*3), 30 tablets/bottle
Approval status
Active

MFDS item code 201702164 · Approved 2017.04.27 · Insurance code 641705330

Summary

Main use
Improvement in blood pressure control for essential hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with renal impairment, dosage adjustment is not necessary in mild to moderate cases, but in severe renal impairment, therapy should begin with a lower dose, gradually increasing as tolerated. For patients with hepatic impairment, the daily dose of telmisartan should not exceed 40 mg.
Child dose
The safety and efficacy of this medication in pediatric patients under the age of 18 have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
일양약품(주)

Efficacy & effects

Improvement in blood pressure control for essential hypertension

  • Essential hypertension
View approved original text

This drug can effectively lower blood pressure when added to the treatment regimen of patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using amlodipine or telmisartan. It plays a critical role in improving hypertension, thereby reducing the risk of cardiovascular complications. Therefore, this medication is used for the treatment of patients with essential hypertension who have difficulty controlling their blood pressure.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with renal impairment, dosage adjustment is not necessary in mild to moderate cases, but in severe renal impairment, therapy should begin with a lower dose, gradually increasing as tolerated. For patients with hepatic impairment, the daily dose of telmisartan should not exceed 40 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under the age of 18 have not been established; therefore, its use is not recommended.

Precautions

This drug poses a serious risk to the fetus if taken during pregnancy, especially in the second and third trimesters. It can lead to impaired kidney function in the fetus, skull formation issues, oliguria, renal failure, and in severe cases, death; thus, use during pregnancy should be avoided. This drug is contraindicated in individuals with allergies to the active or similar ingredients, pregnant or potentially pregnant women, nursing mothers, individuals with cholestatic disease, severe liver disease patients, patients with serious heart conditions, severe hypotensive patients, those in cardiogenic shock, unstable heart failure patients following acute myocardial infarction, and individuals with specific genetic issues. Use this drug cautiously in patients with primary aldosteronism or certain heart valve disorders, and those with impaired liver function. Special attention is warranted for patients with gastrointestinal or kidney diseases, particularly in those with reduced kidney function or the elderly, which may require dosage adjustments and close monitoring. Common side effects include dizziness or peripheral edema, whereas serious side effects such as syncope or cardiac issues may occur infrequently. If side effects are suspected, immediate consultation with a healthcare provider is necessary. If you are pregnant or planning to become pregnant, it is important to stop taking this medication as soon as possible and switch to another safe treatment method. Nursing mothers should also avoid this medication. This medication can interact with other drugs; therefore, be sure to inform your healthcare provider about any other medications being taken, especially lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. In the event of overdose, symptoms such as hypotension, cardiac arrhythmias, and renal failure may arise, necessitating immediate emergency treatment. Keep this medication out of reach of children and ensure it remains sealed until just before administration.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or breathing difficulties, asthma attacks, cough with fever associated respiratory issues, jaundice (yellowing of skin or eyes), extreme malaise, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, coma.

Mild side effects

  • Dizziness
  • peripheral edema
  • syncope
  • headache
  • drowsiness
  • migraine
  • paresthesia
  • dysgeusia
  • tremors
  • visual disturbances (including diplopia)
Show 29 more
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • pruritus
  • diaphoresis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • urinary disorders
  • polyuria.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that effectively blocks light, as it may be sensitive to light. Additionally, it is recommended to keep the medication at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

White or off-white oblong tablets

Package unit

30 tablets (10 tablets/Alu-Alu*3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.